Evaluation of serodiagnosis (beta-D-glucan) screening for invasive fungal infection on intracavitary surgical site infection(SSI)
Not Applicable
- Conditions
- Gastrointestinal surgical patients
- Registration Number
- JPRN-UMIN000003133
- Lead Sponsor
- Miyagi study group for gastrointestinal surgical infection
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Pregnant or patients might be pregnant ,and lactating patients Patients treated with antifungal at study registration Patients diagnosed as fungal infections at study registration Patients not expected to survive during study due to very serious underlying disease or infection Patients considered as inappropriate for study by investigators
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Positive ratio of beta-D-glucan at onset of intracavitary surgical site infections Fungal culture tests
- Secondary Outcome Measures
Name Time Method Incidence of fungal infections at each surgical site Clinical risk factors for fungal infections Usefulness of antifungal treatment